We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
TXO Partners LP
TXO
$787M
| $96 | ﹤0.01% |
5
| – | – |
2024 Q3
2 quarters
|
|
3427
Horizon Technology Finance
HRZN
$308M
| $94 | ﹤0.01% |
10
| – | – |
2024 Q4
1 quarter
|
|
3428
Liberty Global Class A
LBTYA
$2.74B
| $92 | ﹤0.01% |
8
| – | – |
2021 Q3
14 quarters
|
|
3429
Amarin Corp
AMRN
$244M
| $90 | ﹤0.01% |
10
| – | – |
2018 Q4
25 quarters
|
|
3430
Cadre Holdings
CDRE
$1.11B
| $89 | ﹤0.01% |
3
| – | – |
2024 Q4
1 quarter
|
|
3431
Diebold Nixdorf
DBD
$2.26B
| $87 | ﹤0.01% |
2
-2
| -50% | -$87 |
2024 Q3
2 quarters
|
|
3432
Star Holdings Shares of Beneficial Interest
STHO
$96.8M
| $85 | ﹤0.01% |
10
| – | – |
2023 Q1
8 quarters
|
|
3433
Kimbell Royalty Partners
KRP
$1.61B
| $84 | ﹤0.01% |
6
| – | – |
2024 Q2
3 quarters
|
|
3434
Camping World
CWH
$292M
| $81 | ﹤0.01% |
5
-209
| -98% | -$4.27K |
2020 Q2
19 quarters
|
|
3435
Crawford & Co Class B
CRD.B
$568M
| $80 | ﹤0.01% |
+7
| New | +$80 |
2025 Q1
0 quarters
|
|
3436
Editas Medicine
EDIT
$375M
| $70 | ﹤0.01% |
60
| – | – |
2022 Q2
11 quarters
|
|
3437
iShares Global Financials ETF
IXG
$702M
| $70 | ﹤0.01% |
+1
| New | +$102 |
2024 Q4
1 quarter
|
|
3438
Albany International
AIN
$1.72B
| $69 | ﹤0.01% |
1
-10
| -91% | -$777 |
2021 Q2
15 quarters
|
|
3439
Americas Gold and Silver
USAS
$1.31B
| $69 | ﹤0.01% |
52
| – | – |
2022 Q1
12 quarters
|
|
3440
iShares US Pharmaceuticals ETF
IHE
$1.56B
| $67 | ﹤0.01% |
+1
| New | +$69 |
2025 Q1
0 quarters
|
|
3441
Cohen & Steers REIT and Preferred and Income Fund
RNP
$885M
| $66 | ﹤0.01% |
3
| – | – |
2020 Q4
17 quarters
|
|
3442
Ramaco Resources Class B
METCB
$264M
| $64 | ﹤0.01% |
10
| – | – |
2024 Q4
1 quarter
|
|
3443
iShares Genomics Immunology and Healthcare ETF
IDNA
$317M
| $63 | ﹤0.01% |
+3
| New | +$67 |
2025 Q1
0 quarters
|
|
3444
ProShares Ultra S&P500
SSO
$8.94B
| $63 | ﹤0.01% |
+2
| New | +$92 |
2025 Q1
0 quarters
|
|
3445
ChargePoint
CHPT
$194M
| $61 | ﹤0.01% |
5
-125
| -96% | -$2.08K |
2020 Q4
17 quarters
|
|
3446
Loop Industries
LOOP
$18M
| $58 | ﹤0.01% |
50
| – | – |
2018 Q3
26 quarters
|
|
3447
AdvisorShares Pure Cannabis ETF
YOLO
$30.3M
| $53 | ﹤0.01% |
30
| – | – |
2023 Q1
8 quarters
|
|
3448
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $51 | ﹤0.01% |
1
| – | – |
2022 Q2
11 quarters
|
|
3449
ProShares VIX Short-Term Futures ETF
VIXY
$222M
| $50 | ﹤0.01% |
1
| – | – |
2022 Q2
11 quarters
|
|
|
ADAP
3450
DELISTED
Adaptimmune Therapeutics
ADAP
| $49 | ﹤0.01% |
250
| – | – |
2024 Q2
3 quarters
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.